| Long term impact of Covid-19 infection on sleep and mental health: A cross-sectional study GK Ahmed, EM Khedr, DA Hamad, TS Meshref, MM Hashem, MM Aly Psychiatry research 305, 114243, 2021 | 93 | 2021 |
| Rational management approach to pure red cell aplasia SK Balasubramanian, M Sadaps, S Thota, M Aly, BP Przychodzen, ... Haematologica 103 (2), 221, 2018 | 79 | 2018 |
| Combined blood indexes of systemic inflammation as a mirror to admission to intensive care unit in COVID-19 patients: a multicentric study DA Hamad, MM Aly, MA Abdelhameid, SA Ahmed, AS Shaltout, ... Journal of epidemiology and global health, 1-10, 2022 | 68 | 2022 |
| Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes Y Nagata, H Makishima, CM Kerr, BP Przychodzen, M Aly, A Goyal, ... Nature communications 10 (1), 5386, 2019 | 61 | 2019 |
| Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes Y Nagata, S Narumi, Y Guan, BP Przychodzen, CM Hirsch, H Makishima, ... Blood, The Journal of the American Society of Hematology 132 (21), 2309-2313, 2018 | 56 | 2018 |
| Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia H Awada, Y Nagata, A Goyal, MF Asad, B Patel, CM Hirsch, ... Blood advances 3 (3), 339-349, 2019 | 41 | 2019 |
| Distinct clinical and biological implications of CUX1 in myeloid neoplasms M Aly, ZM Ramdzan, Y Nagata, SK Balasubramanian, N Hosono, ... Blood advances 3 (14), 2164-2178, 2019 | 37 | 2019 |
| Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study DAH Mai M Aly , Taghreed S Meshref, Marwa A Abdelhameid, Shimaa A Ahmed ... Journal of Blood Medicine 12 (2021), 505-515, 2021 | 35 | 2021 |
| Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes T Kewan, W Bahaj, A Durmaz, M Aly, OD Ogbue, HE Carraway, ... Blood 141 (14), 1768-1772, 2023 | 23 | 2023 |
| The evolution of paroxysmal nocturnal haemoglobinuria depends on intensity of immunosuppressive therapy T Bat, ON Abdelhamid, SK Balasubramanian, A Mai, T Radivoyevitch, ... British journal of haematology 182 (5), 730, 2018 | 15 | 2018 |
| TP53 mutations and outcome in patients with myelodysplastic syndromes (MDS) K Al-Issa, MA Sekeres, A d Nielsen, B Jha, BP Przychodzen, M Aly, ... Blood 128 (22), 4336, 2016 | 14 | 2016 |
| Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasms SK Balasubramanian, M Aly, Y Nagata, T Bat, BP Przychodzen, ... Leukemia 32 (2), 550-553, 2018 | 12 | 2018 |
| A clinically practicable approach to predict TP53 allelic configurations in myeloid neoplasia W Bahaj, T Kewan, C Gurnari, A Durmaz, BEN Ponvilawan, I Pandit, ... Blood 140 (Supplement 1), 2075-2077, 2022 | 4 | 2022 |
| Revisiting Autoimmunity in Chronic Lymphocytic Leukemia: Prognostic Value of Positive Direct Antiglobulin Test in a Retrospective Study and Literature Review SA Ahmed, GEM Abdallah, MM Aly, EMN Abdelsalam, ... Journal of blood medicine, 225-234, 2021 | 4 | 2021 |
| CXCR4 as a prognostic marker in chronic lymphocytic leukemia patients DAN Wafaa T El-sherif , Eman M Salah El-din , Mai M. Aly , Mohamed G Said The Egyptian Journal of Immunology 28 (2), 114-126, 2021 | 3* | 2021 |
| Impact of SARS-CoV-2 astrazeneca vaccine on safety and blood elements of Egyptian healthcare workers TS Meshref, DA Hamad, MM Aly, DT Kamal, MR Elkhayat, SA Elghazally Indian Journal of Occupational and Environmental Medicine 27 (3), 241-248, 2023 | 2 | 2023 |
| Clinico-Molecular Risk Factors and Management of Thrombosis in a Large Real-Life Cohort of Patients with Paroxysmal Nocturnal Hemoglobinuria in the New Era of Anti-Complement … C Gurnari, H Awada, M Aly, D Dima, F Ullah, N Kawashima, Y Kubota, ... Blood 140 (Supplement 1), 8513-8514, 2022 | 2 | 2022 |
| Extent and clinical implications of subclonal diversity in paroxysmal nocturnal hemoglobinuria MFB Asad, A Goyal, H Awada, M Aly, C Hirsch, MJ Clemente, A Nazha, ... Blood 130, 779, 2017 | 2 | 2017 |
| Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting Y Kubota, X Gu, L Terkawi, J Bodo, BP Przychodzen, H Awada, ... Nature Communications 15 (1), 1832, 2024 | 1 | 2024 |
| Efficacy analysis of different FLT3 inhibitors in patients with relapsed/refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome M Swaminathan, MM Aly, AM Khan, BA Share, V Dhillon, E Lalo, ... EJHaem 4 (1), 165-173, 2023 | 1 | 2023 |
